home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

Rapid Genotyping Of Common Deficient Thiopurine S-Methyltransferase Alleles Using The DNA-Microchip Technique

  August, 31 2006 5:52
your information resource in human molecular genetics

Thiopurine drugs are metabolized, in part, by S-methylation catalyzed by thiopurine S-methyltransferase (TPMT). Patients with very low or undetectable TPMT activity are at high risk of severe, potentially fatal hematopoietic toxicity when they are treated with standard doses of thiopurines. As human TPMT activity is controlled by a common genetic polymorphism, it is an excellent candidate for the clinical application of pharmacogenetics.

In the European Journal of Human Genetics (Vol. 14, pp. 991-998), a group of researches led by Dr. T. V. Nasedkina report a new molecular approach developed to detect point mutations in the TPMT gene that cause the loss of TPMT activity.


Dr. T. V. Nasedkina, Engelhardt Institute of Molecular Biology, 32 Vavilov St, Moscow 119991, Russia.
E-mail: nased@eimb.ru

Abstract available online.

(C) European Journal of Human Genetics.

Posted by: Tressie Dalaya

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.